Vertex Pharmaceuticals advertising spend, FY2025
Vertex Pharmaceuticals (VRTX) reported $203M of advertising expense for the fiscal year ended Dec 31, 2025. That is 1.7% of revenue of $12B. Up 136.6% from FY2024.
Key facts
- Ad spend is 8.3x its FY2015 level ($24.5M), slower than revenue (12x).
- FY2025 is the highest year on file, going back to FY2010.
- Largest increase +136.6% in FY2025; largest cut -66.6% in FY2013.
- Ad spend has risen 2 years in a row.
- Vertex Pharmaceuticals spends more on advertising than 51% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is below the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Advertising was 11.6% of selling, general and administrative expense. Research and development spending was 19x advertising. Advertising equalled 4.9% of operating income.
| Advertising | $203M | AdvertisingExpense |
|---|---|---|
| Selling, general and administrative | $1.8B | ad spend = 11.6% |
| Research and development | $3.9B | R&D = 19x ad spend |
| Operating income | $4.2B | ad spend = 4.9% |
| Net income | $4B |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $203M | +136.6% | $12B | 1.7% | AdvertisingExpense | 10-K Feb 13, 2026 |
| FY2024 | Dec 31, 2024 | $85.7M | +87.1% | $11B | 0.8% | AdvertisingExpense | 10-K Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | $45.8M | n/a | $9.9B | 0.5% | AdvertisingExpense | 10-K Feb 13, 2026 |
| FY2018 | Dec 31, 2018 | $43.5M | +23.6% | $3B | 1.4% | AdvertisingExpense | 10-K Feb 13, 2019 |
| FY2017 | Dec 31, 2017 | $35.2M | +12.1% | $2.5B | 1.4% | AdvertisingExpense | 10-K Feb 13, 2019 |
| FY2016 | Dec 31, 2016 | $31.4M | +28.2% | $1.7B | 1.8% | AdvertisingExpense | 10-K Feb 13, 2019 |
| FY2015 | Dec 31, 2015 | $24.5M | +51.2% | $1B | 2.4% | AdvertisingExpense | 10-K Feb 15, 2018 |
| FY2014 | Dec 31, 2014 | $16.2M | -17.3% | $580M | 2.8% | AdvertisingExpense | 10-K Feb 23, 2017 |
| FY2013 | Dec 31, 2013 | $19.6M | -66.6% | $1.2B | 1.6% | AdvertisingExpense | 10-K Feb 16, 2016 |
| FY2012 | Dec 31, 2012 | $58.6M | +90.3% | $1.5B | 3.8% | AdvertisingExpense | 10-K Feb 13, 2015 |
| FY2011 | Dec 31, 2011 | $30.8M | n/a | $1.4B | 2.2% | AdvertisingExpense | 10-K Feb 11, 2014 |
| FY2010 | Dec 31, 2010 | $0 | n/a | $143M | 0.0% | AdvertisingExpense | 10-K Mar 1, 2013 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank. A $0 value is what the filing tagged for that year.
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to Vertex Pharmaceuticals in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 221 | JOYY | $207M | 9.8% | -13.7% | FY2025 |
| 222 | Atlassian | $206M | 3.1% | +34.8% | FY2026 |
| 223 | Primo Brands | $206M | 3.1% | -5.9% | FY2025 |
| 224 | GoodRx | $203M | 25.5% | -3.8% | FY2025 |
| 225 | Vertex Pharmaceuticals | $203M | 1.7% | +136.6% | FY2025 |
| 226 | American Airlines Group | $200M | 0.4% | +39.9% | FY2025 |
| 227 | PPG Industries | $199M | 1.3% | -2.0% | FY2025 |
Questions
How much does Vertex Pharmaceuticals spend on advertising?
Vertex Pharmaceuticals spent $203M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 13, 2026.
What percentage of revenue does Vertex Pharmaceuticals spend on advertising?
1.7% of revenue in fiscal 2025 ($203M against $12B). The median across the 458 companies tracked is 4.5%.
Is Vertex Pharmaceuticals spending more on advertising?
Yes. Ad spend rose 136.6% in fiscal 2025 from fiscal 2024. It has risen 2 years in a row.
How does Vertex Pharmaceuticals rank by advertising spend?
#225 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does Vertex Pharmaceuticals spend more on advertising than on R&D?
No. In fiscal 2025 it spent $3.9B on research and development and $203M on advertising.
What does Vertex Pharmaceuticals's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Company and source
- Filing
- 10-K for FY2025, filed Feb 13, 2026
- Accession number
0000875320-26-000056- Company
- VERTEX PHARMACEUTICALS INC / MA, CIK 875320, SIC 2834 (Pharmaceutical Preparations)
- Headquarters
- Boston, MA
- Incorporated in
- MA
- Fiscal year ends
- December 31
- Listed on
- Nasdaq
- SEC filer status
- Large accelerated filer
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
- Cite
- Vertex Pharmaceuticals advertising spend, FY2010-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 13, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/vertex-pharmaceuticals-inc-ma/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies